Article Text

Download PDFPDF
Valvular heart diseases
Minimally invasive mitral valve repair

Statistics from


  • Contributors All coauthors contributed to all stages of this manuscript preparation.

  • Funding AMG receives research funding from St. Jude Medical and Tendyne.

  • Competing interests AMG is a consultant for CryoCath Technologies, Edwards Lifesciences, Medtronic, St. Jude Medical, Abbott Laboratories, and Atricure.

  • Provenance and peer review Commissioned; externally peer reviewed.

  • Author note References which include a * in the reference list have been identified as a key reference.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.